News + Filings Transactions
|
FRIEDMAN BENZION ABRAHAM
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/30/2021 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 19.4k | $0.75 | $14.6k | See Footnote | 06/30/2021 |
12/29/2020 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 19.7k | $0.75 | $14.8k | See footnote | 05/18/2017 |
08/20/2020 | Cell Source, Inc. | CLCS | Disposition | Director Stock Option (Right to Buy) | 300k | $0.75 | $225k | | 05/18/2017 |
08/20/2020 | Cell Source, Inc. | CLCS | Grant | Director Stock Option (Right to Buy) | 300k | $0.75 | $225k | See footnote | 05/18/2017 |
08/19/2020 | Cell Source, Inc. | CLCS | Grant | Director Stock Option (Right to Buy) | 300k | $0.75 | $225k | | 05/18/2017 |
06/30/2020 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 19.5k | $0.75 | $14.7k | See footnote | 05/18/2017 |
12/31/2019 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 25.7k | $0.75 | $19.3k | See footnote | 05/18/2017 |
06/26/2019 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 5.4k | $0.75 | $4k | See footnote | 05/18/2017 |
05/07/2019 | Cell Source, Inc. | CLCS | Grant | Series A Convertible Preferred Stock | 31.6k | $0.75 | $23.7k | See footnote | 05/18/2017 |
12/31/2018 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 5.4k | $0.75 | $4.1k | See footnote | 05/18/2017 |
08/21/2018 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 6.7k | $0.75 | $5k | See footnote | 05/18/2017 |
12/04/2017 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 5.4k | $0.75 | $4k | See footnote | 05/18/2017 |
07/26/2017 | Cell Source, Inc. | CLCS | Grant | Series A Convertible Preferred Stock | 12k | $0.75 | $9k | See footnote | 05/18/2017 |
|